Letter: Association of persistently high HBsAg levels during HBeAg‐seropositive stage and hepatocellular carcinoma risk in chronic hepatitis B patients

Letter: Association of persistently high HBsAg levels during HBeAg‐seropositive stage and hepatocellular carcinoma risk in chronic hepatitis B patients—Authors' reply

Published:2024-04-25 Issue:11 Volume:59 Page:1459-1461
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Lin Hsin‐Che¹²^ORCID,Jeng Wen‐Juei³⁴^ORCID,Yang Hwai‐I¹⁵⁶⁷^ORCID

Affiliation:

1. Genomics Research Center Academia Sinica Taipei Taiwan

2. Chang Gung Memorial Hospital, Linkou Branch Taoyuan City Taiwan

3. Department of Gastroenterology and Hepatology Chang Gung Memorial Hospital, Linkou Branch Taoyuan City Taiwan

4. Chang Gung University College of Medicine Taoyuan City Taiwan

5. Institute of Clinical Medicine, National Yang Ming Chiao Tung University Hsinchu Taiwan

6. Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University Kaohsiung Taiwan

7. Biomedical Translation Research Center Academia Sinica Taipei Taiwan

Abstract

LINKED CONTENTThis article is linked to Lin et al papers. To view these articles, visit https://doi.org/10.1111/apt.17915 and https://doi.org/10.1111/apt.17971

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.18009

Reference5 articles.

1. Letter: Association of persistently high HBsAg levels during HBeAg‐seropositive stage and hepatocellular carcinoma risk in chronic hepatitis B patients

2. Persistently high HBsAg levels during HBeAg‐seropositive stage predict lower risk of hepatocellular carcinoma in chronic hepatitis B patients

3. Hepatitis B Surface Antigen Levels Can Be Used to Rule Out Cirrhosis in Hepatitis B e Antigen-Positive Chronic Hepatitis B: Results From the SONIC-B Study

4. Moderate levels of serum hepatitis B virus DNA are associated with the highest risk of hepatocellular carcinoma in chronic hepatitis B patients

5. Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-naïve, e antigen-positive patients